![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
KORU Medical Systems Inc | NASDAQ:KRMD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.23 | 2.10 | 2.37 | 2.35 | 2.21 | 2.24 | 102,502 | 00:37:54 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area
code (
______________________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Item 5.07. Submission of Matters to a Vote of Security Holders.
Set forth below are the voting results from the 2024 Annual Meeting of Shareholders held on May 9, 2024:
Total shares voted: 38,339,108
Proposal 1: Election of Directors
The nominees for director set forth under “Nominees” below were elected to the Company’s board of directors.
Number of Shares | |||
Nominees | For | Withheld | Broker Non-Vote |
R. John Fletcher | 25,929,278 | 1,195,646 | 11,214,184 |
Robert A. Cascella | 26,317,078 | 807,846 | 11,214,184 |
Donna French | 26,864,903 | 260,021 | 11,214,184 |
Joseph M. Manko, Jr. | 26,563,681 | 561,243 | 11,214,184 |
Shahriar (Shar) Matin | 26,858,504 | 266,420 | 11,214,184 |
Linda Tharby | 26,483,272 | 641,652 | 11,214,184 |
Edward Wholihan | 26,459,489 | 665,435 | 11,214,184 |
Proposal 2: Approval, on an advisory basis, of the compensation of the Company’s executive officers.
The Company’s shareholders, on an advisory basis, approved the compensation of the company’s executive officers.
For | Against | Abstain | Broker Non-Vote | |
Number of Shares | 26,409,104 | 541,923 | 173,897 | 11,214,184 |
Proposal 3: Ratification of the appointment of independent registered accountants for the 2024 fiscal year.
The Company’s shareholders ratified the appointment of McGrail Merkel Quinn & Associates, P.C. as the company’s independent registered public accountants for the 2024 fiscal year.
For | Against | Abstain | |
Number of Shares | 38,261,457 | 11,517 | 66,134 |
Proposal 4: Approval of the 2024 Omnibus Equity Incentive Plan.
The Company’s shareholders approved the adoption of the Company’s 2024 Omnibus Equity Incentive Plan.
For | Against | Abstain | |
Number of Shares | 26,146,895 | 814,966 | 163,063 |
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
KORU MEDICAL SYSTEMS, INC. (Registrant) | ||
Date: May 14, 2024 | By: | /s/ Thomas Adams |
Thomas Adams Chief Financial Officer |
- 3 -
Cover |
May 09, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 09, 2024 |
Entity File Number | 0-12305 |
Entity Registrant Name | KORU MEDICAL SYSTEMS, INC. |
Entity Central Index Key | 0000704440 |
Entity Tax Identification Number | 13-3044880 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 100 Corporate Drive |
Entity Address, City or Town | Mahwah |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 07430 |
City Area Code | 845 |
Local Phone Number | 469-2042 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | common stock, $0.01 par value |
Trading Symbol | KRMD |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
1 Year KORU Medical Systems Chart |
1 Month KORU Medical Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions